Patent · US Active

Agent for promoting angiogenesis and methods and uses thereof

US11384130B2 · kind B2 · utility

0Cited by
3References
26Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJan 11, 2018
Grant dateJul 12, 2022
Priority date
Expiry dateNov 4, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates to compounds of Formula (I) which are multimeric forms of a monomeric binding peptide linearly bonded to PEG moieties to form the multimers. The multimeric forms stimulate angiogenesis and promote wound healing. The disclosure also includes pharmaceutical compositions comprising the multimers, including compositions suitable for topical or systemic administration.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.